ICH Q10 - Pharmaceutical Quality System ICH-Q10-Section3-ContinualImprovement-ProcessPerformance-CAPA-ChangeMgmt-MgmtReview: ICH Q10 Section 3 - Continual Improvement + Process Performance and Product Quality Monitoring + CAPA + Change Management + Management Review

Section 3 establishes continual improvement of process performance and product quality. Section 3.1 Process Performance and Product Quality Monitoring: monitor and trend process performance (process capability Cp + Cpk + process performance Pp + Ppk) + product quality (critical quality attributes CQAs) over time; analyse trends + drift + variability + special cause + common cause + identify potential issues before deviation; statistical process control (SPC) + control charts + Westgard rules + Annual Product Quality Review (APQR) per 21 CFR 211.180(e) + EU GMP 1.10; Product Quality Review (PQR) European equivalent. Section 3.2 Corrective Action and Preventive Action (CAPA) System: documented process for identifying + analysing + addressing nonconformances + complaints + recalls + audit findings + deviations + out-of-specification (OOS) + out-of-trend (OOT); root cause analysis (RCA) using 5-Whys + Fishbone Ishikawa + Pareto + Fault Tree Analysis + Failure Mode Effects Analysis FMEA; corrective action (fix nonconformance) + preventive action (prevent recurrence + similar occurrences); effectiveness verification + horizontal expansion to similar products + processes + facilities; CAPA register + tracking + closure + management review. Section 3.3 Change Management System: documented change control covering: change request + impact assessment + risk evaluation per ICH Q9 + technical review + Quality Unit approval + regulatory assessment (variations + post-approval changes) + implementation planning + validation + verification + effectiveness review; change classifications (minor + moderate + major) per EU + FDA + WHO + ICH Q12 Established Conditions; supplier-initiated change notification (SCN) handling. Section 3.4 Management Review of Process Performance and Product Quality: periodic review of monitoring data + CAPA + complaints + recalls + audit findings + supplier performance + trends + improvement initiatives. Internal Audit Programme: independent audit + risk-based + competent auditors + report + closure + management review. Coordinates with FDA cGMP + EU GMP + ICH Q9 QRM + Q12 Lifecycle + ASTM + FDA Process Validation 2011 + PIC/S. ICH Q10 Section 3 + Continual Improvement + Process Performance + CAPA + Change applies.